China announced the relaxation of some of its hardline COVID-19 restrictions on Friday, a day after authorities had vowed to stick to a zero-tolerance virus approach despite mounting economic damage.
Nov 11, 2022
0
20
Bright Health Group will end individual and family health insurance coverage and reduce its Medicare Advantage coverage to just two states, steps that will cut its revenue in half.
Oct 13, 2022
0
23
American drugmaker Pfizer is close to a deal to purchase Global Blood Therapeutics, which manufactures a recently approved drug against sickle-cell anemia, for $5 billion, the Wall Street Journal has reported.
Aug 7, 2022
0
4
British drugs giant GlaxoSmithKline said Tuesday that its consumer healthcare division will be spun off later this year under the name Haleon.
Feb 22, 2022
0
10
Dutch electronics giant Philips said Wednesday it has set aside a further 225 million euros for a recall of faulty respiratory equipment that puts users at risk of inhaling toxic foam.
Jan 12, 2022
0
2
Swiss pharmaceutical giant Novartis said Tuesday it is reviewing the future of its generic medicine division Sandoz, with all options on the table—including spinning it off.
Oct 26, 2021
0
23
Hong Kong suspended use of the Pfizer vaccine Wednesday after its Chinese distributor informed the city that one batch had defective bottle lids.
Mar 24, 2021
0
2
China's drug authority has approved for clinical trials an inhaled COVID-19 vaccine co-developed by domestic firm CanSino Biologics, the company said in a filing on Tuesday.
Mar 23, 2021
0
4
UK pharmaceuticals group AstraZeneca said on Monday it will advance trials of a Covid-19 treatment to a crucial third stage, after the United States invested $486 million (411 million euros) in its development.
Oct 12, 2020
0
0
British consumer health giant Reckitt Benckiser announced Thursday it will pay up to $1.4 billion (1.2 billion euros) to settle a dispute with US authorities over the sale and marketing of an opioid addiction treatment.
Jul 11, 2019
0
1
